<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP02798231B8W1" file="EP02798231W1B8.xml" lang="en" country="EP" doc-number="1432709" kind="B8" correction-code="W1" date-publ="20051102" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEE....SK................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP></eptags></B000><B100><B110>1432709</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20051102</date></B140><B150><B151>W1</B151><B152><date>00000000</date></B152><B153>54</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>02798231.3</B210><B220><date>20020913</date></B220><B240><B241><date>20040327</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>322020 P</B310><B320><date>20010913</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20051102</date><bnum>200544</bnum></B405><B430><date>20040630</date><bnum>200427</bnum></B430><B450><date>20050727</date><bnum>200530</bnum></B450><B452EP><date>20041222</date></B452EP><B480><date>20051102</date><bnum>200544</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7C 07D 471/04   A</B511><B512> 7A 61P  35/00   B</B512></B510><B540><B541>de</B541><B542>1-GLYOXYLAMIDINDOLIZINE ZUR BEHANDLUNG VON KREBS</B542><B541>en</B541><B542>1-GLYOXYLAMIDE INDOLIZINES FOR TREATING CANCER</B542><B541>fr</B541><B542>INDOLIZINES DE 1-GLYOXYLAMIDE PERMETTANT DE TRAITER LE CANCER</B542></B540><B560><B561><text>GB-A- 2 287 706</text></B561><B561><text>US-B1- 6 214 855</text></B561></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>05016203.1</anum></dnum><date>20050726</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>KOYA, Keizo</snm><adr><str>234 Bonad Road</str><city>Chestnut Hill, MA 02467</city><ctry>US</ctry></adr></B721><B721><snm>SUN, Lijun</snm><adr><str>148 Depot Road</str><city>Harvard, MA 01451</city><ctry>US</ctry></adr></B721><B721><snm>ONO, Mitsunori</snm><adr><str>197 Wood Street</str><city>Lexington, MA 02421</city><ctry>US</ctry></adr></B721><B721><snm>YING, Weiwen</snm><adr><str>55 Littleton Road, Unit 29B</str><city>Ayer, MA 01432</city><ctry>US</ctry></adr></B721><B721><snm>LI, Hao</snm><adr><str>73 Park Street, No. 6</str><city>Brookline, MA 02446</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Synta Pharmaceuticals Corporation</snm><iid>04463030</iid><irf>s 2852</irf><adr><str>45 Hartwell Avenue</str><city>Lexington, MA 02421</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Luderschmidt, Schüler &amp; Partner GbR</snm><iid>00101413</iid><adr><str>Patentanwälte, 
John-F.-Kennedy-Strasse 4</str><city>65189 Wiesbaden</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20040327</date></B845EP><B845EP><ctry>LT</ctry><date>20040327</date></B845EP><B845EP><ctry>LV</ctry><date>20040327</date></B845EP><B845EP><ctry>MK</ctry><date>20040327</date></B845EP><B845EP><ctry>RO</ctry><date>20040327</date></B845EP><B845EP><ctry>SI</ctry><date>20040327</date></B845EP></B844EP><B860><B861><dnum><anum>US2002029154</anum></dnum><date>20020913</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2003022846</pnum></dnum><date>20030320</date><bnum>200312</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
